Copyright
©The Author(s) 2023.
World J Hepatol. Feb 27, 2023; 15(2): 237-254
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.237
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.237
Figure 1 Flow chart of patient screening and grouping.
CHB: Chronic hepatitis B; NAFLD: Nonalcoholic fatty liver disease; HIV: Human immunodeficiency virus; AIH: Autoimmune hepatitis; PBC: Primary biliary cholangitis.
- Citation: Tan YW, Wang JM, Zhou XB. Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease. World J Hepatol 2023; 15(2): 237-254
- URL: https://www.wjgnet.com/1948-5182/full/v15/i2/237.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i2.237